CaroGen has  named Harry H. Penner, Jr., to serve as CaroGen’s Chairman of the Board of Directors.

CaroGen’s Co-founder and CEO, Bijan Almassian, PhD, stated, “The election of Mr. Penner, a seasoned leader in biotechnology and pharmaceutical industries, as Chairman of the Board greatly strengthens the CaroGen team, positioning us to execute our Hepatitis B Virus (HBV) program and to continue to build a portfolio of immunotherapies based on our novel Virus-Like Vesicles (VLVs) platform technology”.

Mr. Penner noted that “the CaroGen VLV platform technology holds great promise for addressing unmet needs in several important therapeutic indications, including chronic HBV infection and oncology.”